Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

235
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
235
Positron Emission Tomography01:29

Positron Emission Tomography

5.6K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

165
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
165
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

3.2K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Correlation between Phase Angle and the Number of Medications in Older Inpatients: A Cross-Sectional Study.

Annals of geriatric medicine and research·2026
Same author

Vaccine Ligand Binding Assay Life Cycle Management, Assay Maintenance, Monitoring and Transfer.

Bioanalysis·2026
Same author

Structure-Guided Grafting of Cell-Penetrating Motifs into Stapled Peptides for Intracellular PPI Inhibition.

Journal of medicinal chemistry·2026
Same author

Pressor Response Index During Blood Return as a Marker for Identifying Intradialytic Hypotension.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Correction to "Linker and Conjugation Site Synergy in Antibody-Drug Conjugates: Impacts on Biological Activity".

Bioconjugate chemistry·2026
Same author

[Regulatory Science Study for Ensuring the Quality of Therapeutic extracellular vesicle（EV） Products Including Exosomes and Promoting Their Development].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Related Experiment Video

Updated: Sep 12, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.9K

Recent Trends in Radiopharmaceuticals: Focused on Drug Delivery to the Targeted Tissues.

Takahito Ito1, Akiko Hachisuka1, Akiko Ishii-Watabe2

  • 1Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.

Molecular Pharmaceutics
|August 6, 2025
PubMed
Summary

Radiopharmaceuticals, crucial for precision medicine, utilize radionuclides for targeted diagnosis and therapy. Developing agents with high tissue selectivity enhances efficacy and safety by minimizing radiation exposure to healthy tissues.

Keywords:
drug delivery systemradiopharmaceuticalstheranostics

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.7K

Related Experiment Videos

Last Updated: Sep 12, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.9K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.7K

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Molecular imaging and therapy

Background:

  • Radiopharmaceutical development is accelerating, driven by technological advances and precision medicine needs.
  • Radiopharmaceuticals use radionuclide emissions for therapeutic (alpha/beta particles) or diagnostic (gamma rays) purposes.
  • Theranostics combines diagnostic and therapeutic capabilities through judicious radionuclide selection.

Purpose of the Study:

  • To highlight recent trends in radiopharmaceutical development.
  • To provide a comprehensive classification of radionuclides and targeting ligands.
  • To address the challenge of achieving target tissue selectivity for improved efficacy and safety.

Main Methods:

  • Review of recent advancements in radiopharmaceutical science.
  • Classification of radionuclides based on particle emission properties.
  • Analysis of targeting ligands and their role in biodistribution.

Main Results:

  • Radiopharmaceuticals emitting alpha or beta particles are effective therapeutic agents due to high cytotoxicity.
  • Gamma-emitting radiopharmaceuticals, including those from positron annihilation, are used for diagnostics due to tissue penetration.
  • Achieving high tissue selectivity is critical for diagnostic contrast and therapeutic efficacy, while minimizing off-target radiation exposure.

Conclusions:

  • Targeting ligands are essential for directing radionuclides to specific tissues, overcoming inherent biodistribution limitations.
  • Optimizing radiopharmaceutical design for tissue selectivity is key to advancing precision medicine.
  • This perspective offers a framework for understanding current radiopharmaceutical trends and future directions.